Literature DB >> 18551618

A set of reference sequences for the hepatitis C genotypes 4d, 4f, and 4k covering the full open reading frame.

Thomas Kuntzen1, Andrew Berical, Jean Ndjomou, Phil Bennett, Arne Schneidewind, Niall Lennon, Bruce W Birren, Carla Kuiken, Matthew R Henn, Peter Simmonds, Todd M Allen.   

Abstract

Infection with genotype 4 of the Hepatitis C virus is common in Africa and the Mediterranean area, but has also been found at increasing frequencies in injection drug users in Europe and North America. Full length viral sequences to characterize viral diversity and structure have recently become available mostly for subtype 4a, and studies in Egypt and Saudi Arabia, where high proportions of subtype 4a infected patients exist, have begun to establish optimized treatment regimens. However knowledge about other subtype variants of genotype 4 present in less developed African states is lacking. In this study the full coding region from so far poorly characterized variants of HCV genotype 4 was amplified and sequenced using a long range PCR technique. Sequences were analyzed with respect to phylogenetic relationship, possible recombination and prominent sequence characteristics compared to other known HCV strains. We present for the first time two full-length sequences from the HCV genotype 4k, in addition to five strains from HCV genotypes 4d and 4f. Reference sequences for accurate HCV genotyping are required for optimized treatment, and a better knowledge of the global viral sequence diversity is needed to guide vaccines or new drugs effective in the world wide epidemic.

Entities:  

Mesh:

Year:  2008        PMID: 18551618      PMCID: PMC2818806          DOI: 10.1002/jmv.21240

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  40 in total

Review 1.  Hepatitis C virus infection.

Authors:  G M Lauer; B D Walker
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

Review 2.  Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes.

Authors:  Peter Simmonds; Jens Bukh; Christophe Combet; Gilbert Deléage; Nobuyuki Enomoto; Stephen Feinstone; Phillippe Halfon; Geneviève Inchauspé; Carla Kuiken; Geert Maertens; Masashi Mizokami; Donald G Murphy; Hiroaki Okamoto; Jean-Michel Pawlotsky; François Penin; Erwin Sablon; Tadasu Shin-I; Lieven J Stuyver; Heinz-Jürgen Thiel; Sergei Viazov; Amy J Weiner; Anders Widell
Journal:  Hepatology       Date:  2005-10       Impact factor: 17.425

3.  Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4.

Authors:  F Z Alfaleh; Q Hadad; M S Khuroo; A Aljumah; A Algamedi; H Alashgar; M N Al-Ahdal; I Mayet; M Q Khan; G Kessie
Journal:  Liver Int       Date:  2004-12       Impact factor: 5.828

4.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

5.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

Authors:  Michael W Fried; Mitchell L Shiffman; K Rajender Reddy; Coleman Smith; George Marinos; Fernando L Gonçales; Dieter Häussinger; Moises Diago; Giampiero Carosi; Daniel Dhumeaux; Antonio Craxi; Amy Lin; Joseph Hoffman; Jian Yu
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

6.  Lack of a strong association between HLA class II, tumour necrosis factor and transporter associated with antigen processing gene polymorphisms and virological response to alpha-interferon treatment in patients with chronic hepatitis C.

Authors:  A Airoldi; C Zavaglia; E Silini; C Tinelli; M Martinetti; M Asti; A Rossini; M Vangeli; L Salvaneschi; G Pinzello
Journal:  Eur J Immunogenet       Date:  2004-12

7.  Integrity of the NS5A (amino acid 2209 to 2248) region in hepatitis C virus 1b patients non-responsive to interferon therapy.

Authors:  P Halfon; G Halimi; M Bourlière; D Ouzan; J Durant; H Khiri; L Mercier; V Gerolami; G Cartouzou
Journal:  Liver       Date:  2000-10

8.  A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg.

Authors:  Olga Kalinina; Helene Norder; Sergey Mukomolov; Lars O Magnius
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

9.  Mutations in the NS5A and E2-PePHD region of hepatitis C virus type 1b and correlation with the response to combination therapy with interferon and ribavirin.

Authors:  C-H Hung; C-M Lee; S-N Lu; J-F Lee; J-H Wang; H-D Tung; T-M Chen; T-H Hu; W-J Chen; C-S Changchien
Journal:  J Viral Hepat       Date:  2003-03       Impact factor: 3.728

10.  Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis?

Authors:  G Squadrito; G Raffa; T Restuccia; T Pollicino; S Brancatelli; G Raimondo
Journal:  J Viral Hepat       Date:  2002-09       Impact factor: 3.728

View more
  6 in total

1.  Complete genomic sequences for hepatitis C virus subtypes 4b, 4c, 4d, 4g, 4k, 4l, 4m, 4n, 4o, 4p, 4q, 4r and 4t.

Authors:  Chunhua Li; Ling Lu; Xianghong Wu; Chuanxi Wang; Phil Bennett; Teng Lu; Donald Murphy
Journal:  J Gen Virol       Date:  2009-04-08       Impact factor: 3.891

2.  Whole genome pyrosequencing of rare hepatitis C virus genotypes enhances subtype classification and identification of naturally occurring drug resistance variants.

Authors:  Ruchi M Newman; Thomas Kuntzen; Brian Weiner; Andrew Berical; Patrick Charlebois; Carla Kuiken; Donald G Murphy; Peter Simmonds; Phil Bennett; Niall J Lennon; Bruce W Birren; Michael C Zody; Todd M Allen; Matthew R Henn
Journal:  J Infect Dis       Date:  2012-11-06       Impact factor: 5.226

Review 3.  Recombination in hepatitis C virus.

Authors:  Fernando González-Candelas; F Xavier López-Labrador; María Alma Bracho
Journal:  Viruses       Date:  2011-10-24       Impact factor: 5.048

4.  Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource.

Authors:  Donald B Smith; Jens Bukh; Carla Kuiken; A Scott Muerhoff; Charles M Rice; Jack T Stapleton; Peter Simmonds
Journal:  Hepatology       Date:  2014-01       Impact factor: 17.425

5.  Virological surveillance, molecular phylogeny, and evolutionary dynamics of hepatitis C virus subtypes 1a and 4a isolates in patients from Saudi Arabia.

Authors:  Waleed H AlMalki; Imran Shahid; Ashraf N Abdalla; Ayman K Johargy; Muhammad Ahmed; Sajida Hassan
Journal:  Saudi J Biol Sci       Date:  2020-12-08       Impact factor: 4.219

6.  Highly Diverse Hepatitis C Strains Detected in Sub-Saharan Africa Have Unknown Susceptibility to Direct-Acting Antiviral Treatments.

Authors:  Chris Davis; George S Mgomella; Ana da Silva Filipe; Eric H Frost; Genevieve Giroux; Joseph Hughes; Catherine Hogan; Pontiano Kaleebu; Gershim Asiki; John McLauchlan; Marc Niebel; Ponsiano Ocama; Cristina Pomila; Oliver G Pybus; Jacques Pépin; Peter Simmonds; Joshua B Singer; Vattipally B Sreenu; Clara Wekesa; Elizabeth H Young; Donald G Murphy; Manj Sandhu; Emma C Thomson
Journal:  Hepatology       Date:  2019-03-22       Impact factor: 17.425

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.